Carregant...
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Bisphosphonates are recommended in the treatment of osteoporosis and some cancers, in which case they prevent the appearance of bone metastasis. The patients taking bisphosphonates are at increased risk of developing bisphosphonate-related osteonecrosis of jaw (BRONJ) which is characterised by the p...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3479027/ https://ncbi.nlm.nih.gov/pubmed/22770117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-7-78 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|